Attaching a carrier changes the whole kinetic profile: circulation half-life, volume of distribution and clearance route. We model these shifts before committing to a formulation.
How we work on it
Every programme in this area follows the same staged path: target definition, carrier or formulation engineering, validation in physiologically relevant models, then transfer to continuous-flow GMP production. Read the full technology overview or talk to the team.